Clinical trials
Phase 2 Hepatitis B trials in Taiwan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2007 | 1 |
| 2010 | 2 |
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2020 | 3 |
| 2021 | 3 |
| 2022 | 2 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
| Active, not recruiting | 4 |
| Terminated | 2 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 5 |
| Gilead Sciences | 3 |
| Aligos Therapeutics | 1 |
| Arbutus Biopharma Corporation | 1 |
| Arrowhead Pharmaceuticals | 1 |
| Assembly Biosciences | 1 |
| AusperBio Therapeutics Inc. | 1 |
| Barinthus Biotherapeutics | 1 |
| Bristol-Myers Squibb | 1 |
| F-star Therapeutics, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hepatitis B | 19 |
| Hepatitis B, Chronic | 11 |
| Hepatitis | 5 |
| Hepatitis, Chronic | 2 |
| Acquired Immunodeficiency Syndrome | 1 |
| Blood-Borne Infections | 1 |
| Carcinoma, Hepatocellular | 1 |
| Chronic Disease | 1 |
| Communicable Diseases | 1 |
| DNA Virus Infections | 1 |
Trials
Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.